4.1 Article

Role of the 1 blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial

Related references

Note: Only part of the references are listed.
Editorial Material Clinical Neurology

Topiramate for alcoholism treatment: novel pharmacogenetic evidence for the journey to personalized medicine?

Lorenzo Leggio et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)

Review Substance Abuse

Use of Novel Technology-Based Techniques to Improve Alcohol-Related Outcomes in Clinical Trials

Eugenia M. Gurvich et al.

ALCOHOL AND ALCOHOLISM (2013)

Article Substance Abuse

The 1-Adrenergic Receptor Antagonist, Doxazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats

Meghan L. O'Neil et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)

Article Substance Abuse

The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study

D. Shorter et al.

DRUG AND ALCOHOL DEPENDENCE (2013)

Article Substance Abuse

Prazosin Effects on Stress- and Cue-Induced Craving and Stress Response in Alcohol-Dependent Individuals: Preliminary Findings

Helen C. Fox et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2012)

Article Substance Abuse

Does Family History of Alcoholism Moderate Naltrexone's Effects on Alcohol Use?

Christy Capone et al.

JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2011)

Review Neurosciences

Pharmacogenetic approaches to the treatment of alcohol addiction

Markus Heilig et al.

NATURE REVIEWS NEUROSCIENCE (2011)

Article Substance Abuse

Percentage of Subjects With No Heavy Drinking Days: Evaluation as an Efficacy Endpoint for Alcohol Clinical Trials

Daniel Falk et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2010)

Letter Pharmacology & Pharmacy

Doxazosin Treatment for Posttraumatic Stress Disorder

Joop De Jong et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2010)

Article Substance Abuse

The α1-Adrenergic Receptor Antagonist, Prazosin, Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats

Dennis D. Rasmussen et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)

Article Substance Abuse

A Pilot Trial of the Alpha-1 Adrenergic Antagonist, Prazosin, for Alcohol Dependence

Tracy L. Simpson et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)

Review Psychology, Clinical

Typologies of Alcohol Dependence. From Jellinek to Genetics and Beyond

Lorenzo Leggio et al.

NEUROPSYCHOLOGY REVIEW (2009)

Article Medicine, General & Internal

Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension

Amy I. Lynch et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)

Review Neurosciences

A role for brain stress systems in addiction

George F. Koob

NEURON (2008)

Article Psychology, Biological

Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics

Damaris J. Rohsenow et al.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2007)

Article Medicine, General & Internal

Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial

RF Anton et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)

Article Urology & Nephrology

Terazosin, doxazosin, and prazosin: Current clinical experience

B Akduman et al.

UROLOGY (2001)